Copyright
©The Author(s) 2023.
World J Cardiol. Jun 26, 2023; 15(6): 309-323
Published online Jun 26, 2023. doi: 10.4330/wjc.v15.i6.309
Published online Jun 26, 2023. doi: 10.4330/wjc.v15.i6.309
Figure 3 Increased incidence.
A: Fibrinolysis during the pandemic period; B: Fibrinolysis in low-and middle-income countries as compared to high-income countries. HIC: High-income countries; LMIC: Low- and middle-income countries.
- Citation: Khedr A, Hennawi HA, Khan MK, Elbanna M, Jama AB, Proskuriakova E, Mushtaq H, Mir M, Boike S, Rauf I, Eissa A, Urtecho M, Koritala T, Jain N, Goyal L, Surani S, Khan SA. Effect of fibrinolytic therapy on ST-elevation myocardial infarction clinical outcomes during the COVID-19 pandemic: A systematic review and meta-analysis. World J Cardiol 2023; 15(6): 309-323
- URL: https://www.wjgnet.com/1949-8462/full/v15/i6/309.htm
- DOI: https://dx.doi.org/10.4330/wjc.v15.i6.309